SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Qiagen N.V. (QGEN) trades at a trailing P/E of 19.8, forward P/E of 16.6. Trailing earnings yield is 5.05%, forward earnings yield 6.02%. PEG 0.04 (Peter Lynch undervalued ≤1.0). Graham Number is $28.93.
Criteria proven by this page:
- VALUE (59/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 16.6 (down from trailing 19.8) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.04 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 5.05% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 6.02% as earnings recover.
- Analyst consensus target $54.33 (+30.1% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 74/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
59/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — QGEN
Valuation Multiples
P/E (TTM)19.8
Forward P/E16.6
PEG Ratio0.04
Forward PEG0.71
P/B Ratio2.23
P/S Ratio4.00
EV/EBITDA12.8
Per Share Data
EPS (TTM)$2.05
Forward EPS (Est.)$2.52
Book Value / Share$18.18
Revenue / Share$10.06
FCF / Share$2.18
Yields & Fair Value
Earnings Yield5.05%
Forward Earnings Yield6.02%
Dividend Yield6.56%
Graham Number$28.93
SharesGrow IV$57.39 (+37.4%)
Analyst Target$54.33 (+30.1%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
82.3 |
-2.23 |
2.54 |
4.95 |
- |
| 2017 |
175.9 |
-3.52 |
2.80 |
5.01 |
3.70% |
| 2018 |
41.1 |
0.11 |
2.97 |
5.21 |
- |
| 2019 |
-180.7 |
1.47 |
2.95 |
4.91 |
- |
| 2020 |
32.8 |
-0.12 |
4.22 |
6.31 |
- |
| 2021 |
24.2 |
0.04 |
4.00 |
5.50 |
- |
| 2022 |
26.2 |
-1.50 |
3.20 |
5.18 |
- |
| 2023 |
27.9 |
-1.41 |
2.50 |
4.84 |
- |
| 2024 |
112.7 |
-1.47 |
2.64 |
4.76 |
3.12% |
| 2025 |
23.2 |
0.05 |
2.61 |
4.71 |
0.55% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.35 |
$1.34B |
$80.4M |
6% |
| 2017 |
$0.17 |
$1.42B |
$40.39M |
2.8% |
| 2018 |
$0.82 |
$1.5B |
$190.38M |
12.7% |
| 2019 |
$-0.19 |
$1.53B |
$-41.46M |
-2.7% |
| 2020 |
$0.32 |
$1.87B |
$73.64M |
3.9% |
| 2021 |
$2.28 |
$2.25B |
$512.6M |
22.8% |
| 2022 |
$1.90 |
$2.14B |
$423.21M |
19.8% |
| 2023 |
$1.57 |
$1.97B |
$341.3M |
17.4% |
| 2024 |
$0.37 |
$1.98B |
$83.59M |
4.2% |
| 2025 |
$2.04 |
$2.09B |
$424.88M |
20.3% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$2.52 |
$2.46 – $2.78 |
$2.22B |
$2.2B – $2.23B |
9 |
| 2027 |
$2.77 |
$2.64 – $3.04 |
$2.35B |
$2.33B – $2.37B |
8 |
| 2028 |
$3.02 |
$2.74 – $3.66 |
$2.49B |
$2.49B – $2.49B |
4 |
| 2029 |
$3.27 |
$3.25 – $3.32 |
$2.63B |
$2.62B – $2.66B |
2 |
| 2030 |
$3.54 |
$3.51 – $3.59 |
$2.77B |
$2.76B – $2.8B |
2 |
